GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Cyclically Adjusted Book per Share

Shin Nippon Biomedical Laboratories (FRA:YB3) Cyclically Adjusted Book per Share : €3.14 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's adjusted book value per share for the three months ended in Dec. 2023 was €4.618. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €3.14 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Shin Nippon Biomedical Laboratories's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shin Nippon Biomedical Laboratories was 8.90% per year. The lowest was 5.40% per year. And the median was 7.10% per year.

As of today (2024-06-10), Shin Nippon Biomedical Laboratories's current stock price is €8.05. Shin Nippon Biomedical Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €3.14. Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio of today is 2.56.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shin Nippon Biomedical Laboratories was 7.23. The lowest was 1.22. And the median was 2.26.


Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.89 2.74 2.82 3.06 -

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.06 2.94 3.06 3.14 -

Competitive Comparison of Shin Nippon Biomedical Laboratories's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio falls into.



Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shin Nippon Biomedical Laboratories's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=4.618/106.8000*106.8000
=4.618

Current CPI (Dec. 2023) = 106.8000.

Shin Nippon Biomedical Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201403 1.853 95.700 2.068
201406 1.758 98.000 1.916
201409 1.595 98.500 1.729
201412 1.519 97.900 1.657
201503 1.856 97.900 2.025
201506 2.143 98.400 2.326
201509 2.040 98.500 2.212
201512 3.213 98.100 3.498
201603 3.288 97.900 3.587
201606 3.647 98.100 3.970
201609 4.326 98.000 4.714
201612 3.810 98.400 4.135
201703 4.465 98.100 4.861
201706 3.378 98.500 3.663
201709 3.202 98.800 3.461
201712 4.165 99.400 4.475
201803 4.805 99.200 5.173
201806 4.737 99.200 5.100
201809 6.026 99.900 6.442
201812 5.914 99.700 6.335
201903 5.434 99.700 5.821
201906 4.726 99.800 5.057
201909 4.256 100.100 4.541
201912 3.443 100.500 3.659
202003 3.289 100.300 3.502
202006 3.595 99.900 3.843
202009 2.814 99.900 3.008
202012 2.796 99.300 3.007
202103 2.921 99.900 3.123
202106 3.209 99.500 3.444
202109 3.325 100.100 3.548
202112 3.469 100.100 3.701
202203 3.598 101.100 3.801
202206 3.574 101.800 3.750
202209 4.214 103.100 4.365
202212 4.736 104.100 4.859
202303 4.399 104.400 4.500
202306 4.169 105.200 4.232
202309 4.816 106.200 4.843
202312 4.618 106.800 4.618

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Shin Nippon Biomedical Laboratories  (FRA:YB3) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.05/3.14
=2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shin Nippon Biomedical Laboratories was 7.23. The lowest was 1.22. And the median was 2.26.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shin Nippon Biomedical Laboratories Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines